MedPath

福建天泉药业股份有限公司

Ownership
-
Established
1996-09-03
Employees
-
Market Cap
-
Website
http://www.tianquanyy.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

43

NMPA:43

Drug Approvals

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20253824
Approval Date
Apr 8, 2025
NMPA

Magnesium Sulfate Injection

Product Name
硫酸镁注射液
Approval Number
国药准字H20253825
Approval Date
Apr 8, 2025
NMPA

Diprophylline Injection

Product Name
二羟丙茶碱注射液
Approval Number
国药准字H20253033
Approval Date
Jan 2, 2025
NMPA

Phloroglucinol Injection

Product Name
间苯三酚注射液
Approval Number
国药准字H20249608
Approval Date
Dec 1, 2024
NMPA

Ketorolac Trometamol Injection

Product Name
酮咯酸氨丁三醇注射液
Approval Number
国药准字H20249527
Approval Date
Dec 1, 2024
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20093154
Approval Date
Oct 9, 2023
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20093156
Approval Date
Oct 9, 2023
NMPA

Sodium Chloride Injection

Product Name
氯化钠注射液
Approval Number
国药准字H20093155
Approval Date
Oct 9, 2023
NMPA

Edaravone Injection

Product Name
依达拉奉注射液
Approval Number
国药准字H20227034
Approval Date
Mar 16, 2022
NMPA

Edaravone Injection

Product Name
依达拉奉注射液
Approval Number
国药准字H20110090
Approval Date
Jun 15, 2021
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.